e-learning
resources
Vienna 2012
Monday, 03.09.2012
Idiopathic pulmonary fibrosis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Late stage of experimental pulmonary fibrosis is modulated by collagen V
A. Todorovic Fabro, M. Suzigan de Almeida, I.O. Minatel, E.C. Prado, C. Aparecida Rainho, P.R.T. Walcy, E.R. Parra Cuentas, H. Popper, V. Capelozzi (Botucatu, Brazil)
Source:
Annual Congress 2012 - Idiopathic pulmonary fibrosis
Session:
Idiopathic pulmonary fibrosis
Session type:
Oral Presentation
Number:
2826
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Todorovic Fabro, M. Suzigan de Almeida, I.O. Minatel, E.C. Prado, C. Aparecida Rainho, P.R.T. Walcy, E.R. Parra Cuentas, H. Popper, V. Capelozzi (Botucatu, Brazil). Late stage of experimental pulmonary fibrosis is modulated by collagen V. Eur Respir J 2012; 40: Suppl. 56, 2826
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
Oral immunotherapy with type V collagen in idiopathic pulmonary fibrosis
Source: Eur Respir J 2015; 45: 1393-1402
Year: 2015
Abnormal collagen type V deposition in lung fibroblast is correlated with a worse pulmonary function in systemic sclerosis
Source: Annual Congress 2007 - Miscellaneous interstitial lung diseases related to systemic and other diseases
Year: 2007
Collagen V activation and matrix extracellular remodeling mediated pulmonary fibrosis in experimental models of bleomycin and 3-5-di-tert-4-hidroxitoluene
Source: Annual Congress 2013 –Growth factors at the crossroads of acute and chronic inflammation
Year: 2013
Inhibition of pulmonary collagen-I, III and fibrotic cytokins in bleomycin induced pulmonary fibrosis by okam J201
Source: Eur Respir J 2005; 26: Suppl. 49, 81s
Year: 2005
Pentastatin, matrikine of the type IV collagen a5 drives pulmonary hypertension via endothelial dysfunction
Source: Virtual Congress 2021 – Pathogenesis and pathophysiology of pulmonary hypertension
Year: 2021
Type V collagen nasal tolerance regulates collagen mRNA synthesis in pulmonary remodeling of experimental systemic sclerosis
Source: Annual Congress 2008 - Interstitial lung disease in systemic and vascular disorders
Year: 2008
Collagen V and decorin is involved in systemic sclerosis pulmonary fibrosis
Source: Annual Congress 2011 - The ageing pulmonary interstitium
Year: 2011
Enhanced effects of pirfenidone on the early phase of idiopathic pulmonary fibrosis (IPF)
Source: Annual Congress 2009 - A wide spectrum of idiopathic pulmonary fibrosis
Year: 2009
Refractory remodeling of intrapulmonary arteries by type V collagen, apoptosis and endothelial activation in experimental systemic sclerosis
Source: Annual Congress 2010 - Experimental pulmonary hypertension
Year: 2010
Expression of hyaluronidase by interstitial myofibroblasts and epithelial cells is associated with fibrosis extension, clinical forms and pulmonary function stage in patients with systemic sclerosis
Source: Annual Congress 2010 - Pathogenesis of diffuse parenchymal lung disease
Year: 2010
Assessment of collagen in human idiopathic pulmonary fibrosis using second harmonics on Genesis 200
Source: International Congress 2018 – Back to basics and translational research in idiopathic interstitial pneumonias
Year: 2018
Transplantation of alveolar type II cells in pulmonary fibrosis: experimental studies, MSC in IPF trials
Source: International Congress 2014 – Targeting lung fibrosis: from bench to bedside
Year: 2014
Collagen V nasal tolerance promotes decrease in topoisomerase-1 and pulmonary fibrosis of systemic sclerosis model
Source: Annual Congress 2010 - Experimental approaches in pulmonary fibrosis
Year: 2010
Increased mRNA expression of collagen V gene in pulmonary fibrosis of systemic sclerosis
Source: Annual Congress 2009 - Bronchoalveolar lavage and phenotyping in diffuse parenchymal lung disease
Year: 2009
Pulmonary interstitium remodeling by collagen V is associated with profibrotic cytocines in experimental systemic sclerosis
Source: Annual Congress 2007 - Miscellaneous interstitial lung diseases related to systemic and other diseases
Year: 2007
Increased alveolar soluble annexin V promotes lung inflammation and fibrosis
Source: Eur Respir J 2015; 46: 1417-1429
Year: 2015
Type XIX collagen quantified in serum targeting the anti-tumorigenic NC1 domain is elevated in early and late stage lung carcinoma patients and COPD
Source: Virtual Congress 2020 – Prognostic and predictive factors: treatment of lung cancer
Year: 2020
Adventitial remodeling of experimental pulmonary hypertension induces myofibroblast-produced collagen V in a Th17-pathways-related manner
Source: International Congress 2016 – Pulmonary hypertension: novel insights
Year: 2016
Serum levels of a MMP-12 generated type IV collagen fragment is elevated in COPD and IPF patients
Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases
Year: 2013
Alveolar type II cells transplantation decrease fibrocyte migration in pulmonary fibrosis
Source: Annual Congress 2013 –Novel mechanisms in lung injury
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept